You are here

Eli Lilly

Lilly cancer drug pipeline hit by trial setback

Biopharma Dive

Wed, 10/16/19 - 12:21 pm

pancreatic cancer

ARMO BioSciences

Eli Lilly to shutter neuroscience R&D center next year

Fierce Biotech

Tue, 10/15/19 - 09:44 am

FDA OKs Lilly’s Lasmiditan, First New Acute Migraine Drug in Decades

Xconomy

Fri, 10/11/19 - 10:50 pm

Lilly touts Cyramza lung cancer data, as AZ’s Tagrisso grows even more powerful

Fierce Pharma

Mon, 10/7/19 - 12:18 pm

EGFR lung cancer

FDA approves Pfenex's osteoporosis therapy

Yahoo/Reuters

Mon, 10/7/19 - 10:56 am

Judge Dismisses ‘White Coat’ Whistleblower Allegations Against Bayer, Eli Lilly

BioSpace

Fri, 10/4/19 - 09:49 am

whistleblower lawsuits

Eli Lilly to voluntarily delist from Euronext Paris exchange

Marketwatch

Thu, 10/3/19 - 10:35 am

Mom approved: J&J, Takeda and more lead Working Mother's best places to work list for 2019

Fierce Pharma

Wed, 10/2/19 - 10:53 am

How Big Can This $8 Billion-Plus Diabetes Drug Class Get?

Motley Fool

Fri, 09/27/19 - 09:10 am

Sanofi, AZ, Lilly and more win business in China's expanded cut-price purchase program

Fierce Pharma

Wed, 09/25/19 - 11:30 pm

Sigilon Therapeutics approaches the clinic

EP Vantage

Thu, 09/19/19 - 08:11 pm

How This Pharma Stock Could Knock Eli Lilly Off Its Diabetes Pedestal

Investors Business Daily

Wed, 09/18/19 - 09:53 am

oral semaglutide

Half-Off Sale! Five Major Drugmakers Reveal Vast Gross-to-Net Price Gaps—and Why Rebate Reform Is Still Needed

Drug Channels

Tue, 09/17/19 - 03:35 pm

EASD: Lilly, BI tout new Jardiance kidney analysis as rival J&J nears FDA nod

Fierce Pharma

Tue, 09/17/19 - 11:00 am

Boehringer Ingelheim

Factbox: Britain's insulin providers prepare for Brexit fallout

Yahoo/Reuters

Tue, 09/17/19 - 10:05 am

Three Breast Cancer Drugs: FDA Warns of Rare but Serious Lung Inflammation

RAPS.org

Sun, 09/15/19 - 09:47 pm

ICER dings Novo's new oral diabetes drug

Biopharma Dive

Wed, 09/11/19 - 11:41 pm

oral semaglutide

Boehringer Ingelheim

At Big Lung Cancer Meeting, Lights Shine on KRAS, Drug Combos & More

Xconomy

Mon, 09/9/19 - 08:08 pm

Blueprint Medicines

Lilly's RET drug, nabbed in Loxo buyout, hits 68% ORR in lung cancer

Fierce Biotech

Mon, 09/9/19 - 10:21 am

non-small cell lung cancer

4 Biotech Stocks With Big Catalysts in September

Motley Fool

Thu, 09/5/19 - 10:14 pm

Mirati Therapeutics

Pralsetinibdicines

Pages